Study Shows Lescol Provides Comparable Cholesterol-Lowering Effect As Lipitor, At Higher Doses
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Study Shows Lescol Provides Comparable Cholesterol-Lowering Effect As Lipitor, At Higher Doses

EAST HANOVER, N.J. – Nov. 10, 1998 -- According to a study published in the Nov. 9 issue of the British Journal of Cardiology, treatment with the cholesterol-lowering agents Lescol® (fluvastatin sodium) and Lipitor® (atorvastatin) is comparable at higher doses. In this study, each drug showed a 31 percent reduction in total cholesterol and a 39 percent reduction in low-density lipoprotein cholesterol (LDL-C) at higher doses.

Treatment was initiated at the recommended starting doses of each drug in this study and titrated to Lescol 80 mg or Lipitor 40 mg. At low doses, each drug showed significant reductions in total cholesterol, with a greater reduction demonstrated by Lipitor. This difference in treatment effect diminished as patients were titrated to high doses.

"In this study we saw a wide range of cholesterol-lowering reductions with fluvastatin. This study also demonstrates that fluvastatin can achieve significant lipid-lowering effects at 80 mg," said Herbert Schuster, MD, Max-Delbrueck Center for Molecular Medicine, Berlin, Germany. "Not all patients require the same cholesterol reductions and their needs should drive statin choice and dosage."

The randomized, double-blind trial was conducted at six centers in Germany in 120 men and women with elevated LDL-C >4.2 mmol/L (162.4 mg/dL) and triglyceride levels <3.4 mmol/L (400 mg/dL). Lescol was dosed at 20, 40 and 80 mg per day and Lipitor was given incrementally at 10, 20 and 40 mg per day. In this study, Lescol 80 mg was given as a single dose. However, Lescol 80 mg approval is based on a 40 mg dose taken twice a day. Treatment was initiated at the recommended starting doses for each drug and dosages were increased after four and eight weeks.

Patient characteristics such as gender, baseline lipid values and compliance did not differ between the treatment and placebo groups.

Related Links: Lescol and Lipitor

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities